Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2b, Multi Center, Randomized, Double-Blind, Vehicle-Controlled, Intra-Participant Study, to Evaluate Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Pediatric and Adult Participants (2 Years and Older) With Mild to Moderate Atopic Dermatitis
Brief Summary: This is a Phase 2b, multi-center, randomized, double-blind, vehicle-controlled, intraparticipant study to evaluate efficacy and safety of two regimens of crisaborole ointment 2% in Japanese pediatric and adult participants (cohort 1: 12 years and older, cohort 2: 2 to under 12 years old) with mild to moderate Atopic Dermatitis (AD).


Options:
A: Arm Label: Vehicle Control (VC) Period: Vehicle Cream BID; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle cream | Arm Label: VC Period: Ruxolitinib 0.75% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: VC Period: Ruxolitinib 1.5% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: Long-Term Safety (LTS) Period: Vehicle Cream to Ruxolitinib 0.75% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: LTS Period: Vehicle Cream to Ruxolitinib 1.5% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: LTS Period: Ruxolitinib 0.75% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: LTS Period: Ruxolitinib 1.5% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Intervention Type: DRUG; Name: Ruxolitinib cream; Assigned to Arm(s): LTS Period: Ruxolitinib 0.75% Cream BID, LTS Period: Ruxolitinib 1.5% Cream BID, LTS Period: Vehicle Cream to Ruxolitinib 1.5% Cream BID, Long-Term Safety (LTS) Period: Vehicle Cream to Ruxolitinib 0.75% Cream BID, VC Period: Ruxolitinib 0.75% Cream BID, VC Period: Ruxolitinib 1.5% Cream BID | Intervention Type: DRUG; Name: Vehicle cream; Assigned to Arm(s): Vehicle Control (VC) Period: Vehicle Cream BID
B: Arm Label: Dicillin & Elocon; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dicloxacillin Oral Capsule, Drug: Elocon 0.1 % Topical Cream | Arm Label: Placebo & Elocon; Type: PLACEBO_COMPARATOR; Interventions: Drug: Elocon 0.1 % Topical Cream | Intervention Type: DRUG; Name: Dicloxacillin Oral Capsule; Assigned to Arm(s): Dicillin & Elocon | Intervention Type: DRUG; Name: Elocon 0.1 % Topical Cream; Assigned to Arm(s): Dicillin & Elocon, Placebo & Elocon
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: E6005 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: E6005; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
D: Arm Label: Crisaborole ointment 2% once daily (QD) vs vehicle QD; Type: EXPERIMENTAL; Interventions: Drug: Crisaborole ointment 2%, Drug: Vehicle | Arm Label: Crisaborole ointment 2% twice daily (BID) vs vehicle BID; Type: EXPERIMENTAL; Interventions: Drug: Crisaborole ointment 2%, Drug: Vehicle | Intervention Type: DRUG; Name: Crisaborole ointment 2%; Assigned to Arm(s): Crisaborole ointment 2% twice daily (BID) vs vehicle BID | Intervention Type: DRUG; Name: Vehicle; Assigned to Arm(s): Crisaborole ointment 2% twice daily (BID) vs vehicle BID | Intervention Type: DRUG; Name: Crisaborole ointment 2%; Assigned to Arm(s): Crisaborole ointment 2% once daily (QD) vs vehicle QD | Intervention Type: DRUG; Name: Vehicle; Assigned to Arm(s): Crisaborole ointment 2% once daily (QD) vs vehicle QD

Answer: D